EyePoint Pharmaceuticals is a biopharmaceutical company focuses on developing and commercializing ophthalmic products for the treatment of eye diseases. YUTIQ? (fluocinolone acetonide intravitreal implant) is used for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIPU). DEXYCU? (dexamethasone intraocular suspension) is used for the treatment of post-operative ocular inflammation. The company is entitled to royalties pursuant to license and collaboration agreements utilizing its Durasert technology platform. These include ILUVIEN? for the treatment of diabetic macular edema, ILUVIEN for NIPU, and Retisert? for the treatment of posterior segment uveitis.

Fluidigm creates, manufactures, and markets a range of products and services, including instruments, reagents and software that are used by researchers worldwide. The company markets technologies and life science tools, including preparatory and analytical instruments for Mass Cytometry, polymerase chain reaction, Library Prep, Single Cell Genomics, and consumables, including integrated fluidic circuits, assays, and reagents. The company's product offerings include: Mass Cytometry, Microfluidics and Single Cell Microfluidics.

Intrepid Potash is a mineral company that delivers potassium, magnesium, sulfur, salt, and water products for customer in agriculture, animal feed and the oil and gas industry. The company has three segments: potash, which is applied as a nutrient for healthy crop development, utilized in several industrial applications, and used as an ingredient in animal feed; Trio?, which is the company's specialty fertilizer that delivers potassium, sulfate and magnesium in a single particle and has the added benefit of being low in chloride; and oilfield solutions, in which the company has water rights in New Mexico under which it sells water primarily for industrial uses such as in the oil and gas services industry.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.